Cost-effectiveness of human papillomavirus vaccination in Germany.
Oliver DammJohannes HornRafael T MikolajczykMirjam E E KretzschmarAndreas M KaufmannYvonne DeleréBernhard UltschOle WichmannAlexander KrämerWolfgang GreinerPublished in: Cost effectiveness and resource allocation : C/E (2017)
Our model results suggest that routine HPV vaccination of 12-year-old girls with three doses is likely to be cost-effective in Germany. Due to the additional impact on genital warts, the quadrivalent vaccine appeared to be more cost-effective than the bivalent vaccine. A 2-dose schedule of the quadrivalent vaccine might even lead to cost savings when adopting a societal perspective. The cost-effectiveness of additional vaccination of boys was highly dependent on the coverage in girls.